65,437 trials
Influenza
Primary: Age Adjusted Percentage of Participants With a Physician Visit Due to Any Diagnosis Within 30 Days of the Index Date of the Confirmed Influenza A and B Cases in the…
Distress · Anxiety · Depression
Primary: Brief Symptom Inventory 18 (BSI-18) — 73.3; 74.0; 65.0; 66.8 T-score — p=.912
Asthma
Primary: Symptom Free Days — 9.5; 10.2 Days
Sjogren's Disease
Primary: Ocular Surface Temperature of Both Eyes — 33.95; 34.3; 33.93; 33.95 degrees celcius
Heart Failure
Primary: General Quality of Life From the Standardized Physical Component Score — 31.6; 35.5 units on a scale — p=0.05
Adenocarcinoma of the Esophagus · Adenocarcinomas of the Gastroesophageal Junction · Recurrent Esophageal Cancer
Primary: Overall Response — 2; 4 patients
Sleep · Insomnia · Insulin Resistance
Primary: Plasma Glucose Level at the 120-minute Time Point of a 75g Oral Glucose Tolerance Test
Influenza, Human
Primary: The Frequency and Intensity of Fever Events Occurring During the 7 Days After Each Administration of CSL TIV Vaccine. — 8.2; 4.1; 2.1; 2.1 Percentage of subjects
Dermatitis · Atopic
Primary: Change From Baseline in Pruritus Score — -0.669; -0.638 units on a scale
Head and Neck Cancer · Liver Cancer · Breast Cancer
Primary: Number of Participants With Adverse Events — 23; 23 participants
Tourette's Disorder · Tic Disorder
Primary: Percentage of Participants With Adverse Events. — 76.4; 4.5; 3.6 Percentage of participants
Nausea · Vomiting
Primary: The Change in Numeric Rating Scale in Self-reported Nausea From Baseline Minus 60 Minutes of Treatment. — 1.70; 0.90 units on a scale
Non-Small Cell Lung Cancer
Primary: Percentage of Participants With Dose Limiting Toxicities (DLTs) — 0; 0 Percentage of participants
Hypertension
Primary: Change in Systolic and Diastolic Blood Pressure at Six (6) Months as Measured by Office-based Blood Pressure Assessment — -24.5; -10.3 mm Hg
Colorectal Cancer
Primary: Percentage of Participants With At Least One Adverse Event (AE) — 15.2 percentage of participants